These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9694740)

  • 81. Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study.
    Chornenki NLJ; Siegal DM; Qamar K; Woolgar S; Rangarajan S; Karampatos S; Leong DP; Hillis CM
    Leuk Res; 2022 Feb; 113():106788. PubMed ID: 35042128
    [No Abstract]   [Full Text] [Related]  

  • 82. [Vaquez disease. Diagnosis, course, treatment].
    Bauters F
    Rev Prat; 1998 Sep; 48(13):1483-9. PubMed ID: 10050634
    [No Abstract]   [Full Text] [Related]  

  • 83. Essential thrombocythemia and leukemic transformation.
    Sedlacek SM; Curtis JL; Weintraub J; Levin J
    Medicine (Baltimore); 1986 Nov; 65(6):353-64. PubMed ID: 3465986
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
    Rosati S; Anastasi J; Vardiman J
    Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
    [No Abstract]   [Full Text] [Related]  

  • 85. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders.
    Randi ML; Ruzzon E; Luzzatto G; Tezza F; Girolami A; Fabris F
    Haematologica; 2005 Feb; 90(2):261-2. PubMed ID: 15710584
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular genetic evaluation of myeloproliferative neoplasms.
    Azzato EM; Bagg A
    Int J Lab Hematol; 2015 May; 37 Suppl 1():61-71. PubMed ID: 25976962
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy.
    Kiladjian JJ; Gardin C; Renoux M; Bruno F; Bernard JF
    Hematol J; 2003; 4(3):198-207. PubMed ID: 12764352
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Historical perspective on the treatment of essential thrombocythemia and polycythemia vera.
    Gilbert HS
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):19-22. PubMed ID: 9930553
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cytogenetic abnormalities and leukemic transformation in hydroxyurea-treated patients with Philadelphia chromosome negative chronic myeloproliferative disease.
    Löfvenberg E; Nordenson I; Wahlin A
    Cancer Genet Cytogenet; 1990 Oct; 49(1):57-67. PubMed ID: 2397474
    [TBL] [Abstract][Full Text] [Related]  

  • 91. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.
    Nielsen I; Hasselbalch HC
    Am J Hematol; 2003 Sep; 74(1):26-31. PubMed ID: 12949887
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial.
    Finazzi G; Ruggeri M; Rodeghiero F; Barbui T
    Br J Haematol; 2000 Sep; 110(3):577-83. PubMed ID: 10997967
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases.
    Hirose Y; Masaki Y; Sugai S
    Eur J Haematol; 2002 Feb; 68(2):112-6. PubMed ID: 12061320
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV) patients.
    Spanoudakis E; Bazdiara I; Kotsianidis I; Margaritis D; Goutzouvelidis A; Christoforidou A; Tsatalas C; Bourikas G
    Ann Hematol; 2009 Jul; 88(7):629-32. PubMed ID: 19096846
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The management of chronic myeloid leukaemia--a case history.
    Sureda A; Hernández-Bronchud M
    Ann Oncol; 1997 Jan; 8(1):91-6. PubMed ID: 9093713
    [No Abstract]   [Full Text] [Related]  

  • 97. Leukemic transformation in polycythemia Vera. MPD(UK) Study Group.
    Pearson TC; Green AR; Reilly JT; Harrisoni G
    Blood; 1998 Sep; 92(5):1837-8. PubMed ID: 9716616
    [No Abstract]   [Full Text] [Related]  

  • 98. Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study.
    Barbui T; Ghirardi A; Masciulli A; Carobbio A; Palandri F; Vianelli N; De Stefano V; Betti S; Di Veroli A; Iurlo A; Cattaneo D; Delaini F; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Bertolotti L; Erez D; Gomez M; Wille K; Perez-Encinas M; Lunghi F; Angona A; Fox ML; Beggiato E; Benevolo G; Carli G; Cacciola R; McMullin MF; Tieghi A; Recasens V; Marchetti M; Griesshammer M; Alvarez-Larran A; Vannucchi AM; Finazzi G
    Leukemia; 2019 Aug; 33(8):1996-2005. PubMed ID: 31142846
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Acute myeloid leukemia and myelofibrosis: Simultaneous transformation of essential thrombocythemia during treatment with hydroxyurea.
    Nalluru SS; Efe O; Chen Y; Trivedi N
    J Cancer Res Ther; 2022; 18(4):1180-1182. PubMed ID: 36149183
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Diagnosis and management of neutrophilic myeloid neoplasms.
    Schwede M; Gotlib J; Shomali W
    Clin Adv Hematol Oncol; 2021 Jul; 19(7):450-459. PubMed ID: 34236344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.